Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease

Journal of Bone and Mineral Research

Volumn 19, Issue 7, 2004, Pages 1112-1121

  Taranta, Anna ^a   Fortunati, Dario ^b   Longo, Maurizio ^b   Rucci, Nadia ^c   Iacomino, Enzo ^d   Aliberti, Ferdinando ^e   Facciuto, Enzo ^f   Migliaccio, Silvia ^b   Bardella, Maria Teresa ^g   Dubini, Antonella ^h   Borghi, Maria Orietta ^h   Saraifoger, Silvia ^h   Teti, Anna ^c,i   Bianchi, Maria Luisa ^h  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

^f CARDARELLI HOSPITAL   (Italy)

^g FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^h ISTITUTO AUXOLOGICO ITALIANO   (Italy)

ⁱ NONE   (Italy)

Author keywords

Bone resorption; Celiac disease; Osteoblast; Osteoclast; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYMPHOTOXIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CARRIER PROTEIN; CELL RECEPTOR; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; CYTOKINE; GLUTEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN; MEMBRANE PROTEIN; PARATHYROID HORMONE RELATED PROTEIN; PEPTIDE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BONE CELL; BONE MASS; BONE METABOLISM; BONE TURNOVER; CELIAC DISEASE; CELL ACTIVITY; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DONOR; GLUTEN FREE DIET; HUMAN; HUMAN CELL; INCUBATION TIME; MINERALIZATION; OSTEOCLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; ADULT; BLOOD; BONE DENSITY; CYTOLOGY; FEMALE; GENETICS; MALE; METABOLISM; MONONUCLEAR CELL; OSTEOBLAST; OSTEOLYSIS; URINE;

ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CARRIER PROTEINS; CELIAC DISEASE; COLLAGEN; COLLAGEN TYPE I; CYTOKINES; FEMALE; GLUTEN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); GLYCOPROTEINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE GLYCOPROTEINS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDES; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 16544369698     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.040319     Document Type: Article

References (37)

1. Farrell RJ, Kelly CP 2002 Celiac sprue. N Engl J Med 346:180-188.
2. Collin P, Kaukinen K, Valimaki M, Salmi J 2002 Endocrinological disorders and celiac disease. Endocr Rev 23:464-483.
3. Kemppainen T, Kroger H, Janatuinen E, Arnala I, Kosma VM, Pikkarainen P, Julkunen R, Jurvelin J, Alhava E, Uusitupa M 1999 Osteoporosis in adult patients with celiac disease. Bone 24:249-255.
4. Bianchi ML, Bardella MT 2002 Bone and celiac disease. Calcif Tissue Int 71:465-471.
5. Harada S, Rodan GA 2003 Control of osteoblast function and regulation of bone mass. Nature 423:349-355.
6. Teitelbaum SL 2000 Bone resorption by osteoclasts. Science 289:1504-1508.
7. Boyle WJ, Simonet WS, Lacey DL 2003 Osteoclast differentiation and activation. Nature 423:337-342.
8. Ducy P, Schinke T, Karsenty G 2000 The osteoblast: A sophisticated fibroblast under central surveillance. Science 289:1501-1504.
9. Southerland JC, Valentine JF 2001 Osteopenia and osteoporosis in gastrointestinal diseases: Diagnosis and treatment. Curr Gastroenterol Rep 3:399-407.
10. Selby PL, Davies M, Adams JE, Mawer EB 1999 Bone loss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res 4:652-657.
11. Raisz LG 1999 Physiology and pathophysiology of bone remodeling. Clin Chem 45:1353-1358.
12. Goldring SR 2003 Mechanisms of pathologic bone loss. Calcif Tissue Int 73:97-100.
13. Kontakou M, Przemioslo RT, Sturgess RP, Limb AC, Ciclitira PJ 1996 Expression of tumor necrosis factor-alpha, interleukin-6 and inteleukin-2 mRNA in the jejunum of patients with coeliac disease. Scand J Gastroenterol 30:456-463.
14. Fornari MC, Pedreira S, Niveloni S, Gonzalez D, Diez RA, Vazquez H, Mazure R, Sugai E, Smecuol E, Boerr L, Maurino E, Bai JC 1998 Pre- and post-treatment serum levels of cytokines IL-1beta, 1L-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol 93:413-418.
15. Salvati VM, MacDonald TT, Bajaj-Elliott M, Borrelli M, Staiano A, Auricchio S, Troncone R, Monteleone G 2002 Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 50:186-190.
16. Caselli GF, Mantovanini M, Gandolfi CA, Allegretti M, Fiorentino S, Pellegrini L, Melillo G, Bestini R, Sabbatici W, Anacardio R, Clavenna G, Sciortino G, Teti A 1997 Tartronates: A new generation of drugs affecting bone metabolism. J Bone Miner Res 12:972-981.
17. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A 2000 Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 151:311-320.
18. Chomczynski P, Sacchi N 1987 Single step method of RNA isolated by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 162:156-159.
19. Karsenty G 2003 The complexity of skeletal biology. Nature 423:316-318.
20. Martin RB 2003 Fatigue microdamage as an essential element of bone mechanics and biology. Calcif Tissue Int 73:101-107.
21. Goldring SR, Gravallese EM 2000 Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 12:195-199.
22. Goldring SR 2002 Bone and joint destruction in rheumatoid arthritis: What is really happening? J Rheumatol Suppl 65:44-48.
23. Firestein GS 2003 Evolving concepts of rheumatoid arthritis. Nature 423:356-361.
24. Rodan GA, Martin TJ 2000 Therapeutic approaches to bone diseases. Science 289:1508-1514.
25. Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Giant TT 2001 Osteolysis: Basic science. Clin Orthop 393:71-77.
26. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM 2003 Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111:821-831.
27. Buckley KA, Fraser WD 2002 Receptor activator for nuclear factor kappa B and osteoprotegerin: Regulators of bone physiology and immune responses/potential therapeutic agents and biochemical markers. Ann Clin Biochem 39:551-556.
28. Mizuno A, Kanno T, Hoshi M, Shibata O, Yano K, Fujise N, Kinosaki M, Yamaguchi K, Tsuda E, Murakami A, Yasuda H, Higashio K 2002 Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis. J Bone Miner Metab 20:337-344.
29. Nagata N, Kitaura H, Yoshida N, Nakayama K 2003 Inhibition of RANKL-induced osteoclast formation in mouse marrow cells by IL-12: Involvement of IFN-gamma possibly induced from non-T cell population. Bone 33:721-732.
30. Miossee P 2001 Cytokines in rheumatoid arthritis: Is it all TNF-alpha? Cell Mol Biol 47:675-678.
31. Boneberg EM, Hartung T 2002 Molecular aspects of anti-inflammatory action of G-CSF. Inflamm Res 51:119-128.
32. Horwood NJ, Elliott J, Martin TJ, Gillespie MT 2001 IL-12 alone and in synergy with Il-18 inhibits osteoclast formation in vitro. J Immunol 15:4915-4921.
33. Yamada N, Niwa S, Tsujimura T, Iwasaki T, Sugihara A, Futani H, Hayashi S, Okamura H, Akedo H, Terada N 2002 Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone 30:901-908.
34. Horwood NJ, Udagawa N, Elliott J, Grail D, Okamura H, Kurimoto M, Dunn AR, Martin TJ, Gillespie MT 1998 Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest 101:595-603.
35. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leuna BP, Greer MR, Kennedy K, Carter R, Wei XQ, Xu D, Field M, Foulis A, Liew FY, McInnes IB 1999 A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104:1393-1401.
36. Watrous DA, Andrews BS 1989 The metabolism and immunology of bone. Semin Arthritis Rheum 19:45-65.
37. Hayashi T, Kaneda T, Toyama Y, Kumegawa M, Hakeda Y 2002 Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta) and suppressors of cytokine signaling (SOCS). The possible counter-actine role of SOCSs- in IFN-beta-inhibited osteoclast formation. J Biol Chem 277:27880-27886.